Last Price
0.003
Today's Change
-0.001 (25.00%)
Day's Change
0.003 - 0.004
Trading Volume
213,432
Market Cap
11 Million
Shares Outstanding
3 Billion
Avg Volume
7,469,004
Avg Price (50 Days)
0.00
Avg Price (200 Days)
0.00
PE Ratio
-0.30
EPS
-0.01
Earnings Announcement
04-Feb-2025
Previous Close
0.00
Open
0.00
Day's Range
0.003 - 0.004
Year Range
0.002 - 0.0085
Trading Volume
213,432
1 Day Change
-25.00%
5 Day Change
0.00%
1 Month Change
0.00%
3 Month Change
-25.00%
6 Month Change
-50.00%
Ytd Change
-57.14%
1 Year Change
-57.14%
3 Year Change
-89.66%
5 Year Change
-88.46%
10 Year Change
-98.57%
Max Change
-99.40%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.